Earnings Summary

Amdocs Limited’s revenue jumped 6.52% since last year same period to $1235.96Mn in the Q2 2023. On a quarterly growth basis, Amdocs Limited has generated 1.03% jump in its revenue since last 3-months.

Amdocs Limited’s net profit jumped 24.1% since last year same period to $159.43Mn in the Q2 2023. On a quarterly growth basis, Amdocs Limited has generated 6.57% jump in its net profits since last 3-months.

Amdocs Limited’s net profit margin jumped 16.5% since last year same period to 12.9% in the Q2 2023. On a quarterly growth basis, Amdocs Limited has generated 5.48% jump in its net profit margins since last 3-months.

Amdocs Limited’s earning per share (EPS) estimates for the current quarter stand at 1.25 - a -3.1% fall from last quarter’s estimates.

Amdocs Limited’s earning per share (EPS) estimates for the current year stand at 1.25.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Amdocs Limited’s return on assets (ROA) stands at 0.07.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Amdocs Limited’s return on equity (ROE) stands at 0.16.

Amdocs Limited declared 0.44 dividend per share during the earnings announcement for Q1 2023.